Healthcare provider profile · identity verified

George Michael Lewitt, M.D.

Allopathic & Osteopathic Physicians|Dermatology · NORTHBROOK, IL · NPI 1902031313

Profile state: payments and partd Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

CMS Open Payments records show George Michael Lewitt, M.D. received $773,103.72 in general payments during 2025 across 673 reported records.

ABBVIE INC. accounted for 20.4% of that reported general-payment amount.

The Open Payments records used for this analysis explicitly named 33 associated products.

A separate comparison found the same explicitly named product in public Medicare Part D data: Rinvoq.

ABBVIE INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported RINVOQ as an associated drug or biological on 279238 records involving 34343 distinct recipient NPIs. Public Medicare Part D data also shows 13 claims for Rinvoq by this doctor in 2024.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

$773,103.72

673 reported records · 22 companies

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Who paid this doctor?

Companies in 2025 General Payments

Reported company	Canonical company	Amount	Share	Records	Year
ABBVIE INC.	Unresolved — no canonical attribution shown	$158,038.98	20.4%	98	2025
UCB, Inc.	Unresolved — no canonical attribution shown	$146,603.21	19.0%	119	2025
Janssen Biotech, Inc.	Unresolved — no canonical attribution shown	$116,294.23	15.0%	86	2025
Lilly USA, LLC	Unresolved — no canonical attribution shown	$77,116.24	10.0%	73	2025
Organon LLC	Unresolved — no canonical attribution shown	$48,254.45	6.2%	45	2025
Incyte Corporation	Unresolved — no canonical attribution shown	$45,340.09	5.9%	42	2025
Arcutis Biotherapeutics, Inc.	Unresolved — no canonical attribution shown	$39,482.30	5.1%	41	2025
GENZYME CORPORATION	Unresolved — no canonical attribution shown	$37,597.54	4.9%	24	2025
Galderma Laboratories, L.P.	Unresolved — no canonical attribution shown	$30,437.63	3.9%	50	2025
Amgen Inc.	Unresolved — no canonical attribution shown	$24,757.33	3.2%	24	2025
PFIZER INC.	Unresolved — no canonical attribution shown	$22,327.89	2.9%	18	2025
E.R. Squibb & Sons, L.L.C.	Unresolved — no canonical attribution shown	$15,532.00	2.0%	9	2025
SUN PHARMACEUTICAL INDUSTRIES INC.	Unresolved — no canonical attribution shown	$9,547.57	1.2%	13	2025
Kowa Pharmaceuticals America, Inc.	Unresolved — no canonical attribution shown	$750.00	0.1%	1	2025
Ortho Dermatologics, a division of Bausch Health US, LLC	Unresolved — no canonical attribution shown	$336.69	0.0%	7	2025
Regeneron Healthcare Solutions, Inc.	Unresolved — no canonical attribution shown	$222.37	0.0%	7	2025
LEO Pharma Inc.	Unresolved — no canonical attribution shown	$139.51	0.0%	5	2025
Verrica Pharmaceuticals Inc.	Unresolved — no canonical attribution shown	$96.93	0.0%	2	2025
Botanix SB Inc	Unresolved — no canonical attribution shown	$86.85	0.0%	4	2025
Almirall LLC	Unresolved — no canonical attribution shown	$67.94	0.0%	1	2025
Novartis Pharmaceuticals Corporation	Unresolved — no canonical attribution shown	$52.66	0.0%	3	2025
Journey Medical Corporation	Unresolved — no canonical attribution shown	$21.31	0.0%	1	2025

What were the payments for?

Payment categories

Category	Amount	Records
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program	$581,031.37	165
Consulting Fee	$69,224.27	29
Travel and Lodging	$67,280.51	188
Honoraria	$40,800.00	11
Food and Beverage	$10,807.57	279
Compensation for serving as faculty or as a speaker for a medical education program	$3,960.00	1

A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.

Analysis 1 · Payment-linked products

Products named in Open Payments records

Reported product	Type	Reported company	Related amount*	Records	Year
Bimzelx Normalized: bimzelx	Biological	UCB, Inc.	$141,535.99	116	2025
Source payment records 2025-01-08 · UCB, Inc. · $43.03 · Open Payments source 2025-01-09 · UCB, Inc. · $40.00 · Open Payments source 2025-01-09 · UCB, Inc. · $378.73 · Open Payments source 2025-01-09 · UCB, Inc. · $4,500.00 · Open Payments source 2025-01-09 · UCB, Inc. · $4,500.00 · Open Payments source 2025-01-23 · UCB, Inc. · $4,500.00 · Open Payments source 2025-01-24 · UCB, Inc. · $20.00 · Open Payments source 2025-01-24 · UCB, Inc. · $20.00 · Open Payments source 2025-01-31 · UCB, Inc. · $40.00 · Open Payments source 2025-01-31 · UCB, Inc. · $40.00 · Open Payments source 2025-02-06 · UCB, Inc. · $1,660.00 · Open Payments source 2025-02-10 · UCB, Inc. · $17.50 · Open Payments source 2025-02-10 · UCB, Inc. · $17.50 · Open Payments source 2025-02-13 · UCB, Inc. · $373.02 · Open Payments source 2025-02-13 · UCB, Inc. · $373.03 · Open Payments source 2025-02-13 · UCB, Inc. · $1,660.00 · Open Payments source 2025-02-18 · UCB, Inc. · $135.34 · Open Payments source 2025-02-19 · UCB, Inc. · $20.25 · Open Payments source 2025-02-27 · UCB, Inc. · $33.66 · Open Payments source 2025-02-27 · UCB, Inc. · $4,500.00 · Open Payments source 2025-02-27 · UCB, Inc. · $4,500.00 · Open Payments source 2025-02-27 · UCB, Inc. · $4,500.00 · Open Payments source 2025-03-04 · UCB, Inc. · $63.45 · Open Payments source 2025-03-07 · UCB, Inc. · $20.82 · Open Payments source 2025-03-07 · UCB, Inc. · $443.65 · Open Payments source 2025-03-11 · UCB, Inc. · $117.16 · Open Payments source 2025-03-12 · UCB, Inc. · $35.00 · Open Payments source 2025-03-20 · UCB, Inc. · $4,500.00 · Open Payments source 2025-03-20 · UCB, Inc. · $4,500.00 · Open Payments source 2025-03-21 · UCB, Inc. · $6.88 · Open Payments source 2025-03-21 · UCB, Inc. · $40.00 · Open Payments source 2025-03-21 · UCB, Inc. · $297.48 · Open Payments source 2025-03-27 · UCB, Inc. · $26.44 · Open Payments source 2025-03-27 · UCB, Inc. · $42.88 · Open Payments source 2025-03-27 · UCB, Inc. · $4,500.00 · Open Payments source 2025-04-03 · UCB, Inc. · $4,500.00 · Open Payments source 2025-04-15 · UCB, Inc. · $15.00 · Open Payments source 2025-04-15 · UCB, Inc. · $15.00 · Open Payments source 2025-04-23 · UCB, Inc. · $299.43 · Open Payments source 2025-04-23 · UCB, Inc. · $565.47 · Open Payments source 2025-04-24 · UCB, Inc. · $88.70 · Open Payments source 2025-05-08 · UCB, Inc. · $48.07 · Open Payments source 2025-05-08 · UCB, Inc. · $4,500.00 · Open Payments source 2025-05-08 · UCB, Inc. · $4,500.00 · Open Payments source 2025-05-09 · UCB, Inc. · $35.00 · Open Payments source 2025-05-12 · UCB, Inc. · $18.01 · Open Payments source 2025-05-13 · UCB, Inc. · $15.00 · Open Payments source 2025-05-14 · UCB, Inc. · $15.00 · Open Payments source 2025-05-14 · UCB, Inc. · $15.00 · Open Payments source 2025-05-14 · UCB, Inc. · $15.00 · Open Payments source 2025-05-14 · UCB, Inc. · $113.48 · Open Payments source 2025-05-14 · UCB, Inc. · $508.47 · Open Payments source 2025-05-15 · UCB, Inc. · $15.00 · Open Payments source 2025-05-16 · UCB, Inc. · $15.00 · Open Payments source 2025-05-20 · UCB, Inc. · $203.10 · Open Payments source 2025-05-20 · UCB, Inc. · $203.11 · Open Payments source 2025-05-20 · UCB, Inc. · $203.11 · Open Payments source 2025-05-20 · UCB, Inc. · $6.25 · Open Payments source 2025-05-20 · UCB, Inc. · $6.25 · Open Payments source 2025-05-20 · UCB, Inc. · $6.25 · Open Payments source 2025-05-20 · UCB, Inc. · $6.25 · Open Payments source 2025-05-20 · UCB, Inc. · $48.80 · Open Payments source 2025-05-20 · UCB, Inc. · $48.80 · Open Payments source 2025-05-20 · UCB, Inc. · $48.80 · Open Payments source 2025-05-20 · UCB, Inc. · $48.80 · Open Payments source 2025-05-20 · UCB, Inc. · $203.10 · Open Payments source 2025-05-21 · UCB, Inc. · $35.00 · Open Payments source 2025-05-21 · UCB, Inc. · $487.08 · Open Payments source 2025-05-21 · UCB, Inc. · $487.08 · Open Payments source 2025-05-21 · UCB, Inc. · $487.08 · Open Payments source 2025-05-22 · UCB, Inc. · $131.31 · Open Payments source 2025-05-22 · UCB, Inc. · $353.70 · Open Payments source 2025-05-28 · UCB, Inc. · $35.00 · Open Payments source 2025-05-30 · UCB, Inc. · $4,500.00 · Open Payments source 2025-06-03 · UCB, Inc. · $115.26 · Open Payments source 2025-06-03 · UCB, Inc. · $592.40 · Open Payments source 2025-06-05 · UCB, Inc. · $16.64 · Open Payments source 2025-06-05 · UCB, Inc. · $35.12 · Open Payments source 2025-06-05 · UCB, Inc. · $37.26 · Open Payments source 2025-06-05 · UCB, Inc. · $37.60 · Open Payments source 2025-06-05 · UCB, Inc. · $496.17 · Open Payments source 2025-06-05 · UCB, Inc. · $4,500.00 · Open Payments source 2025-06-05 · UCB, Inc. · $4,500.00 · Open Payments source 2025-06-05 · UCB, Inc. · $5,500.00 · Open Payments source 2025-06-05 · UCB, Inc. · $5,500.00 · Open Payments source 2025-06-20 · UCB, Inc. · $15.00 · Open Payments source 2025-06-20 · UCB, Inc. · $17.06 · Open Payments source 2025-06-20 · UCB, Inc. · $4,500.00 · Open Payments source 2025-06-20 · UCB, Inc. · $4,500.00 · Open Payments source 2025-06-25 · UCB, Inc. · $13.80 · Open Payments source 2025-06-27 · UCB, Inc. · $11.72 · Open Payments source 2025-07-11 · UCB, Inc. · $15.00 · Open Payments source 2025-07-16 · UCB, Inc. · $538.54 · Open Payments source 2025-07-17 · UCB, Inc. · $399.63 · Open Payments source 2025-07-24 · UCB, Inc. · $398.90 · Open Payments source 2025-07-24 · UCB, Inc. · $398.91 · Open Payments source 2025-07-31 · UCB, Inc. · $4,500.00 · Open Payments source 2025-07-31 · UCB, Inc. · $4,500.00 · Open Payments source 2025-08-04 · UCB, Inc. · $29.19 · Open Payments source 2025-08-07 · UCB, Inc. · $4,500.00 · Open Payments source 2025-08-07 · UCB, Inc. · $4,500.00 · Open Payments source 2025-08-16 · UCB, Inc. · $15.00 · Open Payments source 2025-08-19 · UCB, Inc. · $35.00 · Open Payments source 2025-08-28 · UCB, Inc. · $46.19 · Open Payments source 2025-08-28 · UCB, Inc. · $378.88 · Open Payments source 2025-09-11 · UCB, Inc. · $4,500.00 · Open Payments source 2025-09-17 · UCB, Inc. · $29.20 · Open Payments source 2025-10-09 · UCB, Inc. · $42.96 · Open Payments source 2025-10-09 · UCB, Inc. · $431.02 · Open Payments source 2025-10-30 · UCB, Inc. · $15.00 · Open Payments source 2025-10-30 · UCB, Inc. · $4,500.00 · Open Payments source 2025-10-30 · UCB, Inc. · $4,500.00 · Open Payments source 2025-11-06 · UCB, Inc. · $247.50 · Open Payments source 2025-11-19 · UCB, Inc. · $565.72 · Open Payments source 2025-12-12 · UCB, Inc. · $4,500.00 · Open Payments source 2025-12-26 · UCB, Inc. · $2,250.00 · Open Payments source
TREMFYA Normalized: tremfya	Drug	Janssen Biotech, Inc.	$111,619.23	82	2025
Source payment records 2025-01-15 · Janssen Biotech, Inc. · $112.62 · Open Payments source 2025-01-15 · Janssen Biotech, Inc. · $443.94 · Open Payments source 2025-01-17 · Janssen Biotech, Inc. · $58.51 · Open Payments source 2025-01-18 · Janssen Biotech, Inc. · $3,713.00 · Open Payments source 2025-01-23 · Janssen Biotech, Inc. · $984.11 · Open Payments source 2025-01-25 · Janssen Biotech, Inc. · $5,775.00 · Open Payments source 2025-01-25 · Janssen Biotech, Inc. · $3,713.00 · Open Payments source 2025-01-29 · Janssen Biotech, Inc. · $652.30 · Open Payments source 2025-01-29 · Janssen Biotech, Inc. · $99.74 · Open Payments source 2025-02-06 · Janssen Biotech, Inc. · $486.98 · Open Payments source 2025-02-08 · Janssen Biotech, Inc. · $3,713.00 · Open Payments source 2025-02-11 · Janssen Biotech, Inc. · $3,713.00 · Open Payments source 2025-02-25 · Janssen Biotech, Inc. · $16.24 · Open Payments source 2025-02-25 · Janssen Biotech, Inc. · $454.57 · Open Payments source 2025-02-28 · Janssen Biotech, Inc. · $3,713.00 · Open Payments source 2025-03-20 · Janssen Biotech, Inc. · $1,038.88 · Open Payments source 2025-03-22 · Janssen Biotech, Inc. · $3,825.00 · Open Payments source 2025-03-22 · Janssen Biotech, Inc. · $3,825.00 · Open Payments source 2025-03-27 · Janssen Biotech, Inc. · $1,132.01 · Open Payments source 2025-03-28 · Janssen Biotech, Inc. · $2.06 · Open Payments source 2025-03-28 · Janssen Biotech, Inc. · $3.97 · Open Payments source 2025-03-29 · Janssen Biotech, Inc. · $3,825.00 · Open Payments source 2025-03-29 · Janssen Biotech, Inc. · $3,825.00 · Open Payments source 2025-03-29 · Janssen Biotech, Inc. · $3,825.00 · Open Payments source 2025-03-31 · Janssen Biotech, Inc. · $1.40 · Open Payments source 2025-03-31 · Janssen Biotech, Inc. · $13.35 · Open Payments source 2025-04-01 · Janssen Biotech, Inc. · $616.84 · Open Payments source 2025-04-05 · Janssen Biotech, Inc. · $3,825.00 · Open Payments source 2025-04-08 · Janssen Biotech, Inc. · $375.99 · Open Payments source 2025-04-09 · Janssen Biotech, Inc. · $2,094.68 · Open Payments source 2025-04-09 · Janssen Biotech, Inc. · $145.23 · Open Payments source 2025-04-09 · Janssen Biotech, Inc. · $214.24 · Open Payments source 2025-04-09 · Janssen Biotech, Inc. · $316.40 · Open Payments source 2025-04-12 · Janssen Biotech, Inc. · $5,950.00 · Open Payments source 2025-04-12 · Janssen Biotech, Inc. · $3,825.00 · Open Payments source 2025-04-12 · Janssen Biotech, Inc. · $3,825.00 · Open Payments source 2025-04-12 · Janssen Biotech, Inc. · $3,825.00 · Open Payments source 2025-04-14 · Janssen Biotech, Inc. · $469.99 · Open Payments source 2025-04-14 · Janssen Biotech, Inc. · $4.39 · Open Payments source 2025-04-14 · Janssen Biotech, Inc. · $519.44 · Open Payments source 2025-04-14 · Janssen Biotech, Inc. · $35.00 · Open Payments source 2025-04-14 · Janssen Biotech, Inc. · $150.00 · Open Payments source 2025-04-14 · Janssen Biotech, Inc. · $65.00 · Open Payments source 2025-04-19 · Janssen Biotech, Inc. · $850.00 · Open Payments source 2025-04-19 · Janssen Biotech, Inc. · $3,825.00 · Open Payments source 2025-04-19 · Janssen Biotech, Inc. · $3,825.00 · Open Payments source 2025-05-01 · Janssen Biotech, Inc. · $7.10 · Open Payments source 2025-05-01 · Janssen Biotech, Inc. · $0.20 · Open Payments source 2025-05-15 · Janssen Biotech, Inc. · $422.05 · Open Payments source 2025-05-17 · Janssen Biotech, Inc. · $3,825.00 · Open Payments source 2025-06-03 · Janssen Biotech, Inc. · $26.42 · Open Payments source 2025-06-06 · Janssen Biotech, Inc. · $735.00 · Open Payments source 2025-06-23 · Janssen Biotech, Inc. · $30.86 · Open Payments source 2025-07-01 · Janssen Biotech, Inc. · $1.85 · Open Payments source 2025-07-01 · Janssen Biotech, Inc. · $19.98 · Open Payments source 2025-07-10 · Janssen Biotech, Inc. · $394.11 · Open Payments source 2025-07-12 · Janssen Biotech, Inc. · $3,825.00 · Open Payments source 2025-07-26 · Janssen Biotech, Inc. · $1,275.00 · Open Payments source 2025-08-07 · Janssen Biotech, Inc. · $29.05 · Open Payments source 2025-08-19 · Janssen Biotech, Inc. · $27.67 · Open Payments source 2025-08-21 · Janssen Biotech, Inc. · $32.99 · Open Payments source 2025-08-25 · Janssen Biotech, Inc. · $27.57 · Open Payments source 2025-09-02 · Janssen Biotech, Inc. · $7.50 · Open Payments source 2025-09-10 · Janssen Biotech, Inc. · $389.58 · Open Payments source 2025-09-13 · Janssen Biotech, Inc. · $3,825.00 · Open Payments source 2025-09-16 · Janssen Biotech, Inc. · $4.92 · Open Payments source 2025-10-01 · Janssen Biotech, Inc. · $5.67 · Open Payments source 2025-10-01 · Janssen Biotech, Inc. · $24.94 · Open Payments source 2025-10-07 · Janssen Biotech, Inc. · $26.70 · Open Payments source 2025-10-28 · Janssen Biotech, Inc. · $3,825.00 · Open Payments source 2025-11-05 · Janssen Biotech, Inc. · $140.92 · Open Payments source 2025-11-05 · Janssen Biotech, Inc. · $779.16 · Open Payments source 2025-11-08 · Janssen Biotech, Inc. · $3,825.00 · Open Payments source 2025-11-11 · Janssen Biotech, Inc. · $22.83 · Open Payments source 2025-11-17 · Janssen Biotech, Inc. · $7.55 · Open Payments source 2025-11-25 · Janssen Biotech, Inc. · $21.96 · Open Payments source 2025-12-01 · Janssen Biotech, Inc. · $8.07 · Open Payments source 2025-12-02 · Janssen Biotech, Inc. · $27.55 · Open Payments source 2025-12-03 · Janssen Biotech, Inc. · $389.58 · Open Payments source 2025-12-06 · Janssen Biotech, Inc. · $3,825.00 · Open Payments source 2025-12-09 · Janssen Biotech, Inc. · $39.57 · Open Payments source 2025-12-17 · Janssen Biotech, Inc. · $20.00 · Open Payments source
SKYRIZI Normalized: skyrizi	Biological	ABBVIE INC.	$85,413.74	52	2025
Source payment records 2025-01-09 · ABBVIE INC. · $4,000.00 · Open Payments source 2025-01-15 · ABBVIE INC. · $1,035.23 · Open Payments source 2025-01-16 · ABBVIE INC. · $30.43 · Open Payments source 2025-01-24 · ABBVIE INC. · $434.30 · Open Payments source 2025-01-29 · ABBVIE INC. · $457.43 · Open Payments source 2025-01-30 · ABBVIE INC. · $28.98 · Open Payments source 2025-01-30 · ABBVIE INC. · $409.28 · Open Payments source 2025-02-04 · ABBVIE INC. · $31.54 · Open Payments source 2025-02-04 · ABBVIE INC. · $657.08 · Open Payments source 2025-02-11 · ABBVIE INC. · $4,000.00 · Open Payments source 2025-02-11 · ABBVIE INC. · $4,000.00 · Open Payments source 2025-02-21 · ABBVIE INC. · $4,625.00 · Open Payments source 2025-02-28 · ABBVIE INC. · $4,625.00 · Open Payments source 2025-02-28 · ABBVIE INC. · $4,625.00 · Open Payments source 2025-03-06 · ABBVIE INC. · $4,625.00 · Open Payments source 2025-03-12 · ABBVIE INC. · $34.29 · Open Payments source 2025-03-12 · ABBVIE INC. · $553.73 · Open Payments source 2025-03-26 · ABBVIE INC. · $337.05 · Open Payments source 2025-03-31 · ABBVIE INC. · $1,850.00 · Open Payments source 2025-04-01 · ABBVIE INC. · $33.56 · Open Payments source 2025-04-03 · ABBVIE INC. · $4,625.00 · Open Payments source 2025-04-16 · ABBVIE INC. · $361.13 · Open Payments source 2025-04-17 · ABBVIE INC. · $1,901.52 · Open Payments source 2025-04-18 · ABBVIE INC. · $4,625.00 · Open Payments source 2025-05-05 · ABBVIE INC. · $34.10 · Open Payments source 2025-05-08 · ABBVIE INC. · $6,475.00 · Open Payments source 2025-05-20 · ABBVIE INC. · $354.23 · Open Payments source 2025-05-20 · ABBVIE INC. · $232.59 · Open Payments source 2025-05-20 · ABBVIE INC. · $35.47 · Open Payments source 2025-05-20 · ABBVIE INC. · $61.22 · Open Payments source 2025-05-29 · ABBVIE INC. · $481.50 · Open Payments source 2025-06-17 · ABBVIE INC. · $4,625.00 · Open Payments source 2025-06-20 · ABBVIE INC. · $188.92 · Open Payments source 2025-06-25 · ABBVIE INC. · $102.17 · Open Payments source 2025-06-25 · ABBVIE INC. · $481.50 · Open Payments source 2025-07-11 · ABBVIE INC. · $65.13 · Open Payments source 2025-07-17 · ABBVIE INC. · $529.65 · Open Payments source 2025-07-17 · ABBVIE INC. · $122.20 · Open Payments source 2025-07-18 · ABBVIE INC. · $4,625.00 · Open Payments source 2025-08-05 · ABBVIE INC. · $925.00 · Open Payments source 2025-08-06 · ABBVIE INC. · $4,625.00 · Open Payments source 2025-08-14 · ABBVIE INC. · $925.00 · Open Payments source 2025-10-15 · ABBVIE INC. · $28.92 · Open Payments source 2025-10-21 · ABBVIE INC. · $2,775.00 · Open Payments source 2025-11-03 · ABBVIE INC. · $32.65 · Open Payments source 2025-11-04 · ABBVIE INC. · $1,387.50 · Open Payments source 2025-11-17 · ABBVIE INC. · $2,775.00 · Open Payments source 2025-11-25 · ABBVIE INC. · $21.05 · Open Payments source 2025-12-12 · ABBVIE INC. · $25.00 · Open Payments source 2025-12-17 · ABBVIE INC. · $4,625.00 · Open Payments source 2025-12-22 · ABBVIE INC. · $925.00 · Open Payments source 2025-12-22 · ABBVIE INC. · $24.39 · Open Payments source
EBGLYSS Normalized: ebglyss	Drug	Lilly USA, LLC	$71,021.99	60	2025
Source payment records 2025-01-17 · Lilly USA, LLC · $7.34 · Open Payments source 2025-01-20 · Lilly USA, LLC · $22.02 · Open Payments source 2025-02-18 · Lilly USA, LLC · $31.86 · Open Payments source 2025-02-26 · Lilly USA, LLC · $3,200.00 · Open Payments source 2025-02-26 · Lilly USA, LLC · $1,200.00 · Open Payments source 2025-02-28 · Lilly USA, LLC · $3,200.00 · Open Payments source 2025-03-03 · Lilly USA, LLC · $1,200.00 · Open Payments source 2025-03-03 · Lilly USA, LLC · $3,200.00 · Open Payments source 2025-03-11 · Lilly USA, LLC · $2.46 · Open Payments source 2025-03-11 · Lilly USA, LLC · $15.90 · Open Payments source 2025-03-18 · Lilly USA, LLC · $100.30 · Open Payments source 2025-03-24 · Lilly USA, LLC · $3,200.00 · Open Payments source 2025-03-24 · Lilly USA, LLC · $2,000.00 · Open Payments source 2025-04-01 · Lilly USA, LLC · $2.63 · Open Payments source 2025-04-15 · Lilly USA, LLC · $3,200.00 · Open Payments source 2025-04-15 · Lilly USA, LLC · $1,200.00 · Open Payments source 2025-04-21 · Lilly USA, LLC · $3,200.00 · Open Payments source 2025-04-22 · Lilly USA, LLC · $2,800.00 · Open Payments source 2025-04-22 · Lilly USA, LLC · $3,200.00 · Open Payments source 2025-04-29 · Lilly USA, LLC · $21.05 · Open Payments source 2025-05-21 · Lilly USA, LLC · $1,200.00 · Open Payments source 2025-05-21 · Lilly USA, LLC · $3,200.00 · Open Payments source 2025-05-27 · Lilly USA, LLC · $23.17 · Open Payments source 2025-06-05 · Lilly USA, LLC · $8.00 · Open Payments source 2025-06-05 · Lilly USA, LLC · $61.22 · Open Payments source 2025-06-05 · Lilly USA, LLC · $411.97 · Open Payments source 2025-06-05 · Lilly USA, LLC · $44.94 · Open Payments source 2025-06-05 · Lilly USA, LLC · $35.00 · Open Payments source 2025-06-05 · Lilly USA, LLC · $35.47 · Open Payments source 2025-06-05 · Lilly USA, LLC · $237.00 · Open Payments source 2025-06-11 · Lilly USA, LLC · $3,200.00 · Open Payments source 2025-06-11 · Lilly USA, LLC · $2,000.00 · Open Payments source 2025-06-16 · Lilly USA, LLC · $24.92 · Open Payments source 2025-06-23 · Lilly USA, LLC · $3,200.00 · Open Payments source 2025-07-19 · Lilly USA, LLC · $30.30 · Open Payments source 2025-07-22 · Lilly USA, LLC · $1,200.00 · Open Payments source 2025-07-22 · Lilly USA, LLC · $3,200.00 · Open Payments source 2025-07-23 · Lilly USA, LLC · $24.00 · Open Payments source 2025-07-23 · Lilly USA, LLC · $11.50 · Open Payments source 2025-07-25 · Lilly USA, LLC · $34.94 · Open Payments source 2025-07-28 · Lilly USA, LLC · $14.49 · Open Payments source 2025-07-30 · Lilly USA, LLC · $17.20 · Open Payments source 2025-07-31 · Lilly USA, LLC · $3,200.00 · Open Payments source 2025-07-31 · Lilly USA, LLC · $1,200.00 · Open Payments source 2025-08-13 · Lilly USA, LLC · $16.16 · Open Payments source 2025-08-13 · Lilly USA, LLC · $7.99 · Open Payments source 2025-08-13 · Lilly USA, LLC · $0.17 · Open Payments source 2025-08-13 · Lilly USA, LLC · $30.39 · Open Payments source 2025-08-15 · Lilly USA, LLC · $3,200.00 · Open Payments source 2025-08-18 · Lilly USA, LLC · $3,200.00 · Open Payments source 2025-08-18 · Lilly USA, LLC · $2,000.00 · Open Payments source 2025-09-03 · Lilly USA, LLC · $3,200.00 · Open Payments source 2025-09-03 · Lilly USA, LLC · $1,200.00 · Open Payments source 2025-09-11 · Lilly USA, LLC · $45.45 · Open Payments source 2025-09-11 · Lilly USA, LLC · $23.00 · Open Payments source 2025-09-15 · Lilly USA, LLC · $29.30 · Open Payments source 2025-09-23 · Lilly USA, LLC · $32.46 · Open Payments source 2025-10-28 · Lilly USA, LLC · $19.39 · Open Payments source 2025-11-04 · Lilly USA, LLC · $1,200.00 · Open Payments source 2025-11-04 · Lilly USA, LLC · $3,200.00 · Open Payments source
RINVOQ Normalized: rinvoq	Biological	ABBVIE INC.	$62,436.71	36	2025
Source payment records 2025-01-19 · ABBVIE INC. · $122.93 · Open Payments source 2025-02-07 · ABBVIE INC. · $34.23 · Open Payments source 2025-02-07 · ABBVIE INC. · $386.15 · Open Payments source 2025-02-14 · ABBVIE INC. · $34.53 · Open Payments source 2025-02-14 · ABBVIE INC. · $385.20 · Open Payments source 2025-02-21 · ABBVIE INC. · $21.39 · Open Payments source 2025-03-04 · ABBVIE INC. · $4,625.00 · Open Payments source 2025-03-04 · ABBVIE INC. · $4,625.00 · Open Payments source 2025-03-26 · ABBVIE INC. · $72.89 · Open Payments source 2025-03-26 · ABBVIE INC. · $481.50 · Open Payments source 2025-04-11 · ABBVIE INC. · $4,625.00 · Open Payments source 2025-04-24 · ABBVIE INC. · $16.78 · Open Payments source 2025-04-30 · ABBVIE INC. · $123.56 · Open Payments source 2025-04-30 · ABBVIE INC. · $409.28 · Open Payments source 2025-05-08 · ABBVIE INC. · $4,625.00 · Open Payments source 2025-05-08 · ABBVIE INC. · $4,625.00 · Open Payments source 2025-05-09 · ABBVIE INC. · $80.71 · Open Payments source 2025-05-16 · ABBVIE INC. · $4,625.00 · Open Payments source 2025-05-28 · ABBVIE INC. · $48.66 · Open Payments source 2025-05-28 · ABBVIE INC. · $288.90 · Open Payments source 2025-06-16 · ABBVIE INC. · $4,625.00 · Open Payments source 2025-06-24 · ABBVIE INC. · $4,625.00 · Open Payments source 2025-08-13 · ABBVIE INC. · $100.37 · Open Payments source 2025-08-13 · ABBVIE INC. · $385.20 · Open Payments source 2025-09-02 · ABBVIE INC. · $4,625.00 · Open Payments source 2025-09-09 · ABBVIE INC. · $28.44 · Open Payments source 2025-10-03 · ABBVIE INC. · $21.85 · Open Payments source 2025-10-16 · ABBVIE INC. · $6,475.00 · Open Payments source 2025-10-16 · ABBVIE INC. · $116.90 · Open Payments source 2025-10-16 · ABBVIE INC. · $1,261.54 · Open Payments source 2025-10-21 · ABBVIE INC. · $4,625.00 · Open Payments source 2025-11-04 · ABBVIE INC. · $253.00 · Open Payments source 2025-11-04 · ABBVIE INC. · $50.00 · Open Payments source 2025-11-26 · ABBVIE INC. · $49.72 · Open Payments source 2025-11-26 · ABBVIE INC. · $312.98 · Open Payments source 2025-12-17 · ABBVIE INC. · $4,625.00 · Open Payments source
VTAMA Normalized: vtama	Drug	Organon LLC	$48,167.18	41	2025
Source payment records 2025-01-06 · Organon LLC · $4.73 · Open Payments source 2025-02-18 · Organon LLC · $100.77 · Open Payments source 2025-03-03 · Organon LLC · $23.22 · Open Payments source 2025-03-19 · Organon LLC · $6.79 · Open Payments source 2025-03-20 · Organon LLC · $21.84 · Open Payments source 2025-03-27 · Organon LLC · $120.51 · Open Payments source 2025-03-27 · Organon LLC · $610.58 · Open Payments source 2025-04-03 · Organon LLC · $3,200.00 · Open Payments source 2025-04-17 · Organon LLC · $69.44 · Open Payments source 2025-04-23 · Organon LLC · $212.71 · Open Payments source 2025-04-24 · Organon LLC · $7,200.00 · Open Payments source 2025-05-01 · Organon LLC · $3,200.00 · Open Payments source 2025-05-15 · Organon LLC · $102.53 · Open Payments source 2025-05-15 · Organon LLC · $867.40 · Open Payments source 2025-05-27 · Organon LLC · $61.22 · Open Payments source 2025-05-27 · Organon LLC · $134.39 · Open Payments source 2025-05-27 · Organon LLC · $259.62 · Open Payments source 2025-05-27 · Organon LLC · $411.97 · Open Payments source 2025-05-28 · Organon LLC · $3,200.00 · Open Payments source 2025-06-24 · Organon LLC · $140.97 · Open Payments source 2025-07-02 · Organon LLC · $3,200.00 · Open Payments source 2025-07-16 · Organon LLC · $95.25 · Open Payments source 2025-07-16 · Organon LLC · $777.45 · Open Payments source 2025-07-23 · Organon LLC · $58.57 · Open Payments source 2025-07-24 · Organon LLC · $3,200.00 · Open Payments source 2025-09-24 · Organon LLC · $1,414.70 · Open Payments source 2025-10-02 · Organon LLC · $3,200.00 · Open Payments source 2025-10-02 · Organon LLC · $4,800.00 · Open Payments source 2025-10-16 · Organon LLC · $3,200.00 · Open Payments source 2025-11-13 · Organon LLC · $166.50 · Open Payments source 2025-11-13 · Organon LLC · $257.96 · Open Payments source 2025-11-13 · Organon LLC · $360.37 · Open Payments source 2025-11-14 · Organon LLC · $7.75 · Open Payments source 2025-11-14 · Organon LLC · $9.25 · Open Payments source 2025-11-14 · Organon LLC · $20.45 · Open Payments source 2025-11-14 · Organon LLC · $40.00 · Open Payments source 2025-12-10 · Organon LLC · $75.00 · Open Payments source 2025-12-10 · Organon LLC · $191.76 · Open Payments source 2025-12-11 · Organon LLC · $3,200.00 · Open Payments source 2025-12-11 · Organon LLC · $3,200.00 · Open Payments source 2025-12-18 · Organon LLC · $743.48 · Open Payments source
OPZELURA Normalized: opzelura	Drug	Incyte Corporation	$45,340.09	42	2025
Source payment records 2025-02-04 · Incyte Corporation · $29.41 · Open Payments source 2025-02-21 · Incyte Corporation · $2,800.00 · Open Payments source 2025-03-04 · Incyte Corporation · $6.18 · Open Payments source 2025-03-04 · Incyte Corporation · $3.46 · Open Payments source 2025-04-22 · Incyte Corporation · $27.00 · Open Payments source 2025-05-16 · Incyte Corporation · $350.00 · Open Payments source 2025-05-28 · Incyte Corporation · $1,050.00 · Open Payments source 2025-05-28 · Incyte Corporation · $700.00 · Open Payments source 2025-06-09 · Incyte Corporation · $21.96 · Open Payments source 2025-06-30 · Incyte Corporation · $25.20 · Open Payments source 2025-07-03 · Incyte Corporation · $30.52 · Open Payments source 2025-07-10 · Incyte Corporation · $2,800.00 · Open Payments source 2025-08-07 · Incyte Corporation · $24.36 · Open Payments source 2025-08-07 · Incyte Corporation · $24.49 · Open Payments source 2025-08-14 · Incyte Corporation · $474.16 · Open Payments source 2025-08-18 · Incyte Corporation · $26.35 · Open Payments source 2025-08-21 · Incyte Corporation · $4,200.00 · Open Payments source 2025-08-21 · Incyte Corporation · $2,800.00 · Open Payments source 2025-08-27 · Incyte Corporation · $5.00 · Open Payments source 2025-08-27 · Incyte Corporation · $3.50 · Open Payments source 2025-09-04 · Incyte Corporation · $376.98 · Open Payments source 2025-09-11 · Incyte Corporation · $2,800.00 · Open Payments source 2025-09-11 · Incyte Corporation · $4,200.00 · Open Payments source 2025-09-25 · Incyte Corporation · $526.84 · Open Payments source 2025-10-06 · Incyte Corporation · $25.83 · Open Payments source 2025-10-09 · Incyte Corporation · $2,800.00 · Open Payments source 2025-10-09 · Incyte Corporation · $700.00 · Open Payments source 2025-10-13 · Incyte Corporation · $124.50 · Open Payments source 2025-10-13 · Incyte Corporation · $27.53 · Open Payments source 2025-10-13 · Incyte Corporation · $39.55 · Open Payments source 2025-10-17 · Incyte Corporation · $13.58 · Open Payments source 2025-10-23 · Incyte Corporation · $2,800.00 · Open Payments source 2025-10-23 · Incyte Corporation · $2,800.00 · Open Payments source 2025-11-05 · Incyte Corporation · $377.14 · Open Payments source 2025-11-13 · Incyte Corporation · $2,800.00 · Open Payments source 2025-11-20 · Incyte Corporation · $377.14 · Open Payments source 2025-12-03 · Incyte Corporation · $396.48 · Open Payments source 2025-12-11 · Incyte Corporation · $2,800.00 · Open Payments source 2025-12-11 · Incyte Corporation · $2,800.00 · Open Payments source 2025-12-17 · Incyte Corporation · $323.77 · Open Payments source 2025-12-23 · Incyte Corporation · $29.16 · Open Payments source 2025-12-23 · Incyte Corporation · $2,800.00 · Open Payments source
ZORYVE Normalized: zoryve	Drug	Arcutis Biotherapeutics, Inc., Kowa Pharmaceuticals America, Inc.	$40,232.30	42	2025
Source payment records 2025-01-19 · Arcutis Biotherapeutics, Inc. · $37.93 · Open Payments source 2025-02-20 · Arcutis Biotherapeutics, Inc. · $13.22 · Open Payments source 2025-02-25 · Arcutis Biotherapeutics, Inc. · $5.63 · Open Payments source 2025-03-10 · Arcutis Biotherapeutics, Inc. · $5.64 · Open Payments source 2025-03-20 · Arcutis Biotherapeutics, Inc. · $3.86 · Open Payments source 2025-04-04 · Arcutis Biotherapeutics, Inc. · $11.00 · Open Payments source 2025-04-07 · Arcutis Biotherapeutics, Inc. · $20.74 · Open Payments source 2025-04-22 · Arcutis Biotherapeutics, Inc. · $7.30 · Open Payments source 2025-05-14 · Arcutis Biotherapeutics, Inc. · $8.07 · Open Payments source 2025-06-20 · Arcutis Biotherapeutics, Inc. · $303.97 · Open Payments source 2025-06-20 · Arcutis Biotherapeutics, Inc. · $326.97 · Open Payments source 2025-06-21 · Arcutis Biotherapeutics, Inc. · $92.08 · Open Payments source 2025-06-21 · Arcutis Biotherapeutics, Inc. · $138.91 · Open Payments source 2025-06-21 · Arcutis Biotherapeutics, Inc. · $103.10 · Open Payments source 2025-07-09 · Arcutis Biotherapeutics, Inc. · $3,750.00 · Open Payments source 2025-07-09 · Arcutis Biotherapeutics, Inc. · $150.37 · Open Payments source 2025-07-09 · Arcutis Biotherapeutics, Inc. · $6,187.50 · Open Payments source 2025-08-20 · Arcutis Biotherapeutics, Inc. · $23.53 · Open Payments source 2025-08-22 · Arcutis Biotherapeutics, Inc. · $655.74 · Open Payments source 2025-08-29 · Arcutis Biotherapeutics, Inc. · $3,375.00 · Open Payments source 2025-09-09 · Arcutis Biotherapeutics, Inc. · $7.63 · Open Payments source 2025-10-09 · Arcutis Biotherapeutics, Inc. · $3,375.00 · Open Payments source 2025-10-16 · Kowa Pharmaceuticals America, Inc. · $750.00 · Open Payments source 2025-10-21 · Arcutis Biotherapeutics, Inc. · $15.05 · Open Payments source 2025-11-06 · Arcutis Biotherapeutics, Inc. · $19.69 · Open Payments source 2025-11-12 · Arcutis Biotherapeutics, Inc. · $15.20 · Open Payments source 2025-11-12 · Arcutis Biotherapeutics, Inc. · $138.34 · Open Payments source 2025-11-13 · Arcutis Biotherapeutics, Inc. · $3,375.00 · Open Payments source 2025-11-13 · Arcutis Biotherapeutics, Inc. · $3,375.00 · Open Payments source 2025-11-14 · Arcutis Biotherapeutics, Inc. · $38.65 · Open Payments source 2025-11-15 · Arcutis Biotherapeutics, Inc. · $422.34 · Open Payments source 2025-11-19 · Arcutis Biotherapeutics, Inc. · $3,375.00 · Open Payments source 2025-11-24 · Arcutis Biotherapeutics, Inc. · $6.06 · Open Payments source 2025-11-24 · Arcutis Biotherapeutics, Inc. · $1,500.00 · Open Payments source 2025-12-13 · Arcutis Biotherapeutics, Inc. · $487.80 · Open Payments source 2025-12-13 · Arcutis Biotherapeutics, Inc. · $24.94 · Open Payments source 2025-12-17 · Arcutis Biotherapeutics, Inc. · $23.15 · Open Payments source 2025-12-17 · Arcutis Biotherapeutics, Inc. · $3,375.00 · Open Payments source 2025-12-18 · Arcutis Biotherapeutics, Inc. · $440.66 · Open Payments source 2025-12-19 · Arcutis Biotherapeutics, Inc. · $165.46 · Open Payments source 2025-12-19 · Arcutis Biotherapeutics, Inc. · $706.77 · Open Payments source 2025-12-19 · Arcutis Biotherapeutics, Inc. · $3,375.00 · Open Payments source
DUPIXENT Normalized: dupixent	Biological	GENZYME CORPORATION, Regeneron Healthcare Solutions, Inc.	$37,819.91	31	2025
Source payment records 2025-02-05 · Regeneron Healthcare Solutions, Inc. · $33.46 · Open Payments source 2025-02-17 · GENZYME CORPORATION · $70.56 · Open Payments source 2025-03-18 · GENZYME CORPORATION · $34.24 · Open Payments source 2025-03-19 · Regeneron Healthcare Solutions, Inc. · $27.26 · Open Payments source 2025-05-05 · GENZYME CORPORATION · $854.00 · Open Payments source 2025-05-15 · Regeneron Healthcare Solutions, Inc. · $37.14 · Open Payments source 2025-06-01 · GENZYME CORPORATION · $4,270.00 · Open Payments source 2025-06-19 · Regeneron Healthcare Solutions, Inc. · $31.01 · Open Payments source 2025-06-30 · GENZYME CORPORATION · $854.00 · Open Payments source 2025-07-02 · GENZYME CORPORATION · $31.81 · Open Payments source 2025-07-09 · GENZYME CORPORATION · $854.00 · Open Payments source 2025-08-26 · Regeneron Healthcare Solutions, Inc. · $31.01 · Open Payments source 2025-09-05 · Regeneron Healthcare Solutions, Inc. · $26.83 · Open Payments source 2025-09-06 · GENZYME CORPORATION · $115.00 · Open Payments source 2025-09-06 · GENZYME CORPORATION · $2,892.00 · Open Payments source 2025-09-06 · GENZYME CORPORATION · $215.46 · Open Payments source 2025-09-06 · GENZYME CORPORATION · $15.40 · Open Payments source 2025-09-10 · GENZYME CORPORATION · $5,551.00 · Open Payments source 2025-09-10 · GENZYME CORPORATION · $640.23 · Open Payments source 2025-09-24 · GENZYME CORPORATION · $117.39 · Open Payments source 2025-09-24 · GENZYME CORPORATION · $4,697.00 · Open Payments source 2025-09-24 · GENZYME CORPORATION · $609.75 · Open Payments source 2025-10-16 · GENZYME CORPORATION · $33.58 · Open Payments source 2025-10-16 · GENZYME CORPORATION · $4,697.00 · Open Payments source 2025-10-16 · GENZYME CORPORATION · $1,036.57 · Open Payments source 2025-10-16 · GENZYME CORPORATION · $121.86 · Open Payments source 2025-10-16 · GENZYME CORPORATION · $4,697.00 · Open Payments source 2025-11-13 · Regeneron Healthcare Solutions, Inc. · $35.66 · Open Payments source 2025-11-20 · GENZYME CORPORATION · $35.38 · Open Payments source 2025-11-20 · GENZYME CORPORATION · $4,697.00 · Open Payments source 2025-11-20 · GENZYME CORPORATION · $457.31 · Open Payments source
OTEZLA Normalized: otezla	Drug	Amgen Inc.	$24,757.33	24	2025
Source payment records 2025-02-17 · Amgen Inc. · $49.09 · Open Payments source 2025-04-03 · Amgen Inc. · $21.17 · Open Payments source 2025-04-21 · Amgen Inc. · $2,126.77 · Open Payments source 2025-04-30 · Amgen Inc. · $1,637.50 · Open Payments source 2025-05-02 · Amgen Inc. · $3,275.00 · Open Payments source 2025-05-10 · Amgen Inc. · $30.30 · Open Payments source 2025-05-21 · Amgen Inc. · $2,947.50 · Open Payments source 2025-05-30 · Amgen Inc. · $6.82 · Open Payments source 2025-06-17 · Amgen Inc. · $9.67 · Open Payments source 2025-08-06 · Amgen Inc. · $120.89 · Open Payments source 2025-08-08 · Amgen Inc. · $387.26 · Open Payments source 2025-08-14 · Amgen Inc. · $4,200.00 · Open Payments source 2025-09-15 · Amgen Inc. · $18.69 · Open Payments source 2025-10-07 · Amgen Inc. · $7.12 · Open Payments source 2025-10-27 · Amgen Inc. · $315.00 · Open Payments source 2025-10-27 · Amgen Inc. · $20.84 · Open Payments source 2025-10-31 · Amgen Inc. · $4,200.00 · Open Payments source 2025-10-31 · Amgen Inc. · $440.20 · Open Payments source 2025-10-31 · Amgen Inc. · $700.00 · Open Payments source 2025-10-31 · Amgen Inc. · $19.27 · Open Payments source 2025-11-04 · Amgen Inc. · $4,200.00 · Open Payments source 2025-11-04 · Amgen Inc. · $17.36 · Open Payments source 2025-11-19 · Amgen Inc. · $2.94 · Open Payments source 2025-12-18 · Amgen Inc. · $3.94 · Open Payments source
NEMLUVIO Normalized: nemluvio	Drug	Galderma Laboratories, L.P.	$24,093.83	33	2025
Source payment records 2025-01-21 · Galderma Laboratories, L.P. · $17.09 · Open Payments source 2025-02-10 · Galderma Laboratories, L.P. · $2,700.00 · Open Payments source 2025-05-20 · Galderma Laboratories, L.P. · $18.99 · Open Payments source 2025-06-17 · Galderma Laboratories, L.P. · $11.99 · Open Payments source 2025-06-25 · Galderma Laboratories, L.P. · $10.79 · Open Payments source 2025-07-23 · Galderma Laboratories, L.P. · $20.36 · Open Payments source 2025-08-01 · Galderma Laboratories, L.P. · $600.00 · Open Payments source 2025-08-04 · Galderma Laboratories, L.P. · $17.67 · Open Payments source 2025-08-06 · Galderma Laboratories, L.P. · $10.08 · Open Payments source 2025-08-07 · Galderma Laboratories, L.P. · $44.92 · Open Payments source 2025-08-08 · Galderma Laboratories, L.P. · $34.97 · Open Payments source 2025-08-15 · Galderma Laboratories, L.P. · $3,600.00 · Open Payments source 2025-08-15 · Galderma Laboratories, L.P. · $3,600.00 · Open Payments source 2025-08-15 · Galderma Laboratories, L.P. · $13.44 · Open Payments source 2025-08-22 · Galderma Laboratories, L.P. · $22.88 · Open Payments source 2025-08-22 · Galderma Laboratories, L.P. · $473.85 · Open Payments source 2025-08-22 · Galderma Laboratories, L.P. · $30.00 · Open Payments source 2025-08-29 · Galderma Laboratories, L.P. · $9,300.00 · Open Payments source 2025-09-12 · Galderma Laboratories, L.P. · $5.00 · Open Payments source 2025-09-12 · Galderma Laboratories, L.P. · $3.08 · Open Payments source 2025-09-15 · Galderma Laboratories, L.P. · $82.75 · Open Payments source 2025-09-15 · Galderma Laboratories, L.P. · $587.46 · Open Payments source 2025-09-15 · Galderma Laboratories, L.P. · $63.39 · Open Payments source 2025-09-15 · Galderma Laboratories, L.P. · $89.91 · Open Payments source 2025-09-15 · Galderma Laboratories, L.P. · $384.80 · Open Payments source 2025-09-22 · Galderma Laboratories, L.P. · $24.70 · Open Payments source 2025-10-05 · Galderma Laboratories, L.P. · $15.93 · Open Payments source 2025-11-10 · Galderma Laboratories, L.P. · $19.70 · Open Payments source 2025-11-22 · Galderma Laboratories, L.P. · $8.96 · Open Payments source 2025-11-22 · Galderma Laboratories, L.P. · $21.59 · Open Payments source 2025-11-22 · Galderma Laboratories, L.P. · $47.16 · Open Payments source 2025-11-26 · Galderma Laboratories, L.P. · $2,190.00 · Open Payments source 2025-12-01 · Galderma Laboratories, L.P. · $22.37 · Open Payments source
CIBINQO Normalized: cibinqo	Drug	PFIZER INC.	$22,327.89	18	2025
Source payment records 2025-01-08 · PFIZER INC. · $17.32 · Open Payments source 2025-02-06 · PFIZER INC. · $23.13 · Open Payments source 2025-02-10 · PFIZER INC. · $22.48 · Open Payments source 2025-02-15 · PFIZER INC. · $131.97 · Open Payments source 2025-03-10 · PFIZER INC. · $17.44 · Open Payments source 2025-05-23 · PFIZER INC. · $18.04 · Open Payments source 2025-06-05 · PFIZER INC. · $122.32 · Open Payments source 2025-06-09 · PFIZER INC. · $4,000.00 · Open Payments source 2025-06-13 · PFIZER INC. · $574.58 · Open Payments source 2025-07-01 · PFIZER INC. · $18.17 · Open Payments source 2025-07-07 · PFIZER INC. · $21.00 · Open Payments source 2025-08-18 · PFIZER INC. · $720.00 · Open Payments source 2025-09-15 · PFIZER INC. · $4,275.00 · Open Payments source 2025-10-09 · PFIZER INC. · $4,000.00 · Open Payments source 2025-10-14 · PFIZER INC. · $90.37 · Open Payments source 2025-10-29 · PFIZER INC. · $26.07 · Open Payments source 2025-11-17 · PFIZER INC. · $4,125.00 · Open Payments source 2025-11-20 · PFIZER INC. · $4,125.00 · Open Payments source
Sotyktu Normalized: sotyktu	Drug	E.R. Squibb & Sons, L.L.C.	$13,572.00	8	2025
Source payment records 2025-01-17 · E.R. Squibb & Sons, L.L.C. · $2,805.00 · Open Payments source 2025-04-03 · E.R. Squibb & Sons, L.L.C. · $11.72 · Open Payments source 2025-04-03 · E.R. Squibb & Sons, L.L.C. · $500.12 · Open Payments source 2025-04-15 · E.R. Squibb & Sons, L.L.C. · $3,920.00 · Open Payments source 2025-05-15 · E.R. Squibb & Sons, L.L.C. · $5.04 · Open Payments source 2025-06-06 · E.R. Squibb & Sons, L.L.C. · $1,960.00 · Open Payments source 2025-11-05 · E.R. Squibb & Sons, L.L.C. · $450.12 · Open Payments source 2025-11-26 · E.R. Squibb & Sons, L.L.C. · $3,920.00 · Open Payments source
ILUMYA Normalized: ilumya	Biological	SUN PHARMACEUTICAL INDUSTRIES INC.	$9,326.93	8	2025
Source payment records 2025-02-17 · SUN PHARMACEUTICAL INDUSTRIES INC. · $3,250.00 · Open Payments source 2025-04-07 · SUN PHARMACEUTICAL INDUSTRIES INC. · $1,760.00 · Open Payments source 2025-05-06 · SUN PHARMACEUTICAL INDUSTRIES INC. · $25.09 · Open Payments source 2025-07-12 · SUN PHARMACEUTICAL INDUSTRIES INC. · $136.71 · Open Payments source 2025-08-27 · SUN PHARMACEUTICAL INDUSTRIES INC. · $3,960.00 · Open Payments source 2025-08-27 · SUN PHARMACEUTICAL INDUSTRIES INC. · $121.37 · Open Payments source 2025-09-23 · SUN PHARMACEUTICAL INDUSTRIES INC. · $35.00 · Open Payments source 2025-11-24 · SUN PHARMACEUTICAL INDUSTRIES INC. · $38.76 · Open Payments source
VYALEV Normalized: vyalev	Drug	ABBVIE INC.	$9,237.11	8	2025
Source payment records 2025-08-09 · ABBVIE INC. · $23.97 · Open Payments source 2025-08-09 · ABBVIE INC. · $57.53 · Open Payments source 2025-08-09 · ABBVIE INC. · $22.50 · Open Payments source 2025-08-09 · ABBVIE INC. · $67.12 · Open Payments source 2025-08-21 · ABBVIE INC. · $588.00 · Open Payments source 2025-08-21 · ABBVIE INC. · $128.49 · Open Payments source 2025-08-21 · ABBVIE INC. · $24.50 · Open Payments source 2025-08-21 · ABBVIE INC. · $8,325.00 · Open Payments source
AKLIEF Normalized: aklief	Drug	Galderma Laboratories, L.P.	$6,215.98	3	2025
Source payment records 2025-06-12 · Galderma Laboratories, L.P. · $2,600.00 · Open Payments source 2025-08-26 · Galderma Laboratories, L.P. · $15.98 · Open Payments source 2025-09-18 · Galderma Laboratories, L.P. · $3,600.00 · Open Payments source
Cabtreo Normalized: cabtreo	Drug	Ortho Dermatologics, a division of Bausch Health US, LLC	$336.69	7	2025
Source payment records 2025-02-28 · Ortho Dermatologics, a division of Bausch Health US, LLC · $19.96 · Open Payments source 2025-04-21 · Ortho Dermatologics, a division of Bausch Health US, LLC · $14.59 · Open Payments source 2025-05-19 · Ortho Dermatologics, a division of Bausch Health US, LLC · $20.80 · Open Payments source 2025-07-21 · Ortho Dermatologics, a division of Bausch Health US, LLC · $147.28 · Open Payments source 2025-08-18 · Ortho Dermatologics, a division of Bausch Health US, LLC · $23.66 · Open Payments source 2025-09-08 · Ortho Dermatologics, a division of Bausch Health US, LLC · $88.67 · Open Payments source 2025-12-21 · Ortho Dermatologics, a division of Bausch Health US, LLC · $21.73 · Open Payments source
SILIQ Normalized: siliq	Drug	Ortho Dermatologics, a division of Bausch Health US, LLC	$316.73	6	2025
Source payment records 2025-04-21 · Ortho Dermatologics, a division of Bausch Health US, LLC · $14.59 · Open Payments source 2025-05-19 · Ortho Dermatologics, a division of Bausch Health US, LLC · $20.80 · Open Payments source 2025-07-21 · Ortho Dermatologics, a division of Bausch Health US, LLC · $147.28 · Open Payments source 2025-08-18 · Ortho Dermatologics, a division of Bausch Health US, LLC · $23.66 · Open Payments source 2025-09-08 · Ortho Dermatologics, a division of Bausch Health US, LLC · $88.67 · Open Payments source 2025-12-21 · Ortho Dermatologics, a division of Bausch Health US, LLC · $21.73 · Open Payments source
TALTZ Normalized: taltz	Drug	Lilly USA, LLC	$271.32	14	2025
Source payment records 2025-01-17 · Lilly USA, LLC · $7.34 · Open Payments source 2025-01-20 · Lilly USA, LLC · $22.02 · Open Payments source 2025-02-18 · Lilly USA, LLC · $31.86 · Open Payments source 2025-03-11 · Lilly USA, LLC · $2.46 · Open Payments source 2025-03-11 · Lilly USA, LLC · $15.90 · Open Payments source 2025-04-01 · Lilly USA, LLC · $2.63 · Open Payments source 2025-04-29 · Lilly USA, LLC · $21.05 · Open Payments source 2025-06-16 · Lilly USA, LLC · $24.92 · Open Payments source 2025-07-19 · Lilly USA, LLC · $30.30 · Open Payments source 2025-07-28 · Lilly USA, LLC · $14.49 · Open Payments source 2025-07-30 · Lilly USA, LLC · $17.20 · Open Payments source 2025-09-15 · Lilly USA, LLC · $29.30 · Open Payments source 2025-09-23 · Lilly USA, LLC · $32.46 · Open Payments source 2025-10-28 · Lilly USA, LLC · $19.39 · Open Payments source
LITFULO Normalized: litfulo	Drug	PFIZER INC.	$163.65	8	2025
Source payment records 2025-01-08 · PFIZER INC. · $17.32 · Open Payments source 2025-02-06 · PFIZER INC. · $23.13 · Open Payments source 2025-02-10 · PFIZER INC. · $22.48 · Open Payments source 2025-03-10 · PFIZER INC. · $17.44 · Open Payments source 2025-05-23 · PFIZER INC. · $18.04 · Open Payments source 2025-07-01 · PFIZER INC. · $18.17 · Open Payments source 2025-07-07 · PFIZER INC. · $21.00 · Open Payments source 2025-10-29 · PFIZER INC. · $26.07 · Open Payments source
JUBLIA Normalized: jublia	Drug	Ortho Dermatologics, a division of Bausch Health US, LLC	$100.74	5	2025
Source payment records 2025-02-28 · Ortho Dermatologics, a division of Bausch Health US, LLC · $19.96 · Open Payments source 2025-04-21 · Ortho Dermatologics, a division of Bausch Health US, LLC · $14.59 · Open Payments source 2025-05-19 · Ortho Dermatologics, a division of Bausch Health US, LLC · $20.80 · Open Payments source 2025-08-18 · Ortho Dermatologics, a division of Bausch Health US, LLC · $23.66 · Open Payments source 2025-12-21 · Ortho Dermatologics, a division of Bausch Health US, LLC · $21.73 · Open Payments source
YCANTH Normalized: ycanth	Drug	Verrica Pharmaceuticals Inc.	$96.93	2	2025
Source payment records 2025-01-19 · Verrica Pharmaceuticals Inc. · $73.98 · Open Payments source 2025-10-02 · Verrica Pharmaceuticals Inc. · $22.95 · Open Payments source
SOFDRA Normalized: sofdra	Drug	Botanix SB Inc	$86.85	4	2025
Source payment records 2025-02-11 · Botanix SB Inc · $23.39 · Open Payments source 2025-04-08 · Botanix SB Inc · $17.61 · Open Payments source 2025-06-03 · Botanix SB Inc · $23.12 · Open Payments source 2025-10-14 · Botanix SB Inc · $22.73 · Open Payments source
ADBRY Normalized: adbry	Biological	LEO Pharma Inc.	$68.23	3	2025
Source payment records 2025-01-27 · LEO Pharma Inc. · $21.87 · Open Payments source 2025-03-26 · LEO Pharma Inc. · $23.59 · Open Payments source 2025-06-02 · LEO Pharma Inc. · $22.77 · Open Payments source
Klisyri Normalized: klisyri	Drug	Almirall LLC	$67.94	1	2025
Source payment records 2025-01-19 · Almirall LLC · $67.94 · Open Payments source
COSENTYX Normalized: cosentyx	Drug	Novartis Pharmaceuticals Corporation	$52.66	3	2025
Source payment records 2025-03-06 · Novartis Pharmaceuticals Corporation · $18.34 · Open Payments source 2025-05-07 · Novartis Pharmaceuticals Corporation · $17.26 · Open Payments source 2025-09-03 · Novartis Pharmaceuticals Corporation · $17.06 · Open Payments source
NEXPLANON Normalized: nexplanon	Drug	Organon LLC	$47.63	2	2025
Source payment records 2025-08-11 · Organon LLC · $34.69 · Open Payments source 2025-08-12 · Organon LLC · $12.94 · Open Payments source
Winlevi Normalized: winlevi	Drug	SUN PHARMACEUTICAL INDUSTRIES INC.	$37.30	2	2025
Source payment records 2025-09-08 · SUN PHARMACEUTICAL INDUSTRIES INC. · $17.95 · Open Payments source 2025-12-03 · SUN PHARMACEUTICAL INDUSTRIES INC. · $19.35 · Open Payments source
BOTOX Normalized: botox	Biological	ABBVIE INC.	$26.42	1	2025
Source payment records 2025-06-25 · ABBVIE INC. · $26.42 · Open Payments source
Leqselvi Normalized: leqselvi	Biological	SUN PHARMACEUTICAL INDUSTRIES INC.	$25.45	1	2025
Source payment records 2025-11-18 · SUN PHARMACEUTICAL INDUSTRIES INC. · $25.45 · Open Payments source
ANZUPGO Normalized: anzupgo	Drug	LEO Pharma Inc.	$24.81	1	2025
Source payment records 2025-12-15 · LEO Pharma Inc. · $24.81 · Open Payments source
EUCRISA Normalized: eucrisa	Drug	PFIZER INC.	$17.32	1	2025
Source payment records 2025-01-08 · PFIZER INC. · $17.32 · Open Payments source
DYSPORT Normalized: dysport	Drug	Galderma Laboratories, L.P.	$14.37	1	2025
Source payment records 2025-02-03 · Galderma Laboratories, L.P. · $14.37 · Open Payments source

* Product-associated amounts are non-additive because one payment record may name more than one product.

These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.

Public prescribing for products named in payments

Open Payments product	Payment year	Part D brand	Part D year	Claims	Match method	Source
RINVOQ rinvoq	2025	Rinvoq	2024	13 Beneficiary count suppressed	exact normalized	Medicare Part D

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

Paying company	Payment year	Drug reported by same entity	Open Payments evidence	Part D	Claims	Beneficiaries
ABBVIE INC. Exact reporting entity; no affiliate inference	2025	RINVOQ open payments reported associated product	CMS Open Payments — General Payments 279238 supporting records · 34343 recipient NPIs · example record 1201352600	Rinvoq · 2024 Exact normalized brand match · 1 Part D row	13	suppressed by CMS

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Ketoconazole	Ketoconazole	128	61
Dupixent Pen	Dupilumab	74	suppressed
Minoxidil	Minoxidil	44	14
Triamcinolone Acetonide	Triamcinolone Acetonide	43	31
Hydrocortisone	Hydrocortisone	28	16
Mometasone Furoate	Mometasone Furoate	23	15
Ciclopirox	Ciclopirox	22	suppressed
Clobetasol Propionate	Clobetasol Propionate	22	14
Fluorouracil	Fluorouracil	20	15
Betamethasone Dipropionate	Betamethasone Dipropionate	19	15
Clindamycin Phosphate	Clindamycin Phosphate	18	13
Mupirocin	Mupirocin	18	14
Fluticasone Propionate	Fluticasone Propionate	15	13
Doxycycline Hyclate	Doxycycline Hyclate	14	11
Rinvoq	Upadacitinib	13	suppressed
Valacyclovir	Valacyclovir Hcl	13	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	$773,103.72 · 673 records	ABBVIE INC.	ADBRY, AKLIEF, ANZUPGO, BOTOX, Bimzelx, CIBINQO, COSENTYX, Cabtreo, DUPIXENT, DYSPORT, EBGLYSS, EUCRISA, ILUMYA, JUBLIA, Klisyri, LITFULO, Leqselvi, NEMLUVIO, NEXPLANON, OPZELURA, OTEZLA, RINVOQ, SILIQ, SKYRIZI, SOFDRA, Sotyktu, TALTZ, TREMFYA, VTAMA, VYALEV, Winlevi, YCANTH, ZORYVE	1	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

What role, if any, does Rinvoq play in your treatment recommendations for me?
How do you evaluate evidence when you have a financial relationship with ABBVIE INC.?
Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error